Norman A Wiggins

Title: The Innovations of Norman A. Wiggins

Introduction

Norman A. Wiggins is a notable inventor based in Wilmington, DE (US). He has made significant contributions to the field of pharmaceuticals, holding a total of 2 patents. His work focuses on developing innovative pharmaceutical compositions that aim to improve health outcomes.

Latest Patents

Wiggins' latest patents include groundbreaking pharmaceutical compositions. One patent relates to a composition containing (E)-7-[4-(4-fluorophenyl)-6-isopropyl-2-[methyl(methylsulfonyl)amino]pyrimidin-5-yl]-(3R, 5S)-3,5-dihydroxyhept-6-enoic acid or a pharmaceutically-acceptable salt thereof as the active ingredient, combined with an inorganic salt featuring a multivalent cation. Another patent concerns a pharmaceutical composition comprising the HMG CoA reductase inhibitor (E)-7-[4-(4-fluorophenyl)-6-isopropyl-2-[methyl(methylsulfonyl)amino]pyrimidin-5-yl]-(3R,5S)-3,5-dihydroxyhept-6-enoic acid or a pharmaceutically acceptable salt thereof, which remains stable over an extended period.

Career Highlights

Wiggins is currently associated with AstraZeneca AB, a leading global biopharmaceutical company. His work at AstraZeneca has allowed him to contribute to the development of innovative treatments that address various health issues. His expertise in pharmaceutical compositions has positioned him as a valuable asset in the industry.

Collaborations

Wiggins collaborates with Joseph Richard Creekmore, enhancing the research and development efforts within their field. Their partnership exemplifies the importance of teamwork in driving innovation and achieving successful outcomes in pharmaceutical research.

Conclusion

Norman A. Wiggins is a distinguished inventor whose contributions to pharmaceutical compositions have the potential to make a significant impact on healthcare. His innovative work continues to advance the field and improve patient outcomes.